Framework for Implementing and Tracking a Molecular Tumor Board at a National Cancer Institute–Designated Comprehensive Cancer Center
Plain-language summary
As tumor genetic sequencing panels grew to cover hundreds of genes, oncologists increasingly struggled to interpret the results and choose treatments, so Vanderbilt-Ingram Cancer Center set up two molecular tumor boards: one for its own patients and a global community board open to a wider population. These boards bring together oncologists, pathologists, geneticists, and genetic counselors to review cases and produce formal treatment recommendations documented in the medical record. By December 2020 the boards had discussed over 170 institutional cases from 77 providers plus 58 international cases from six countries, and the authors share their best practices as a framework other institutions can replicate.
Read the full paper (DOI: 10.1002/onco.13936).
This is a plain-language summary written for discoverability; the authoritative version is the published paper. Part of Travis Osterman's peer-reviewed publications.